Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC
- 1 August 2003
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 90 (2) , 265-272
- https://doi.org/10.1016/s0090-8258(03)00248-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Cationic Liposome-MediatedE1AGene Transfer to Human Breast and Ovarian Cancer Cells and Its Biologic Effects: A Phase I Clinical TrialJournal of Clinical Oncology, 2001
- Successful Treatment of Primary and Disseminated Human Lung Cancers by Systemic Delivery of Tumor Suppressor Genes Using an Improved Liposome VectorMolecular Therapy, 2001
- Development of cationic liposome formulations for intratracheal gene therapy of early lung cancerCancer Gene Therapy, 2000
- LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growthGene Therapy, 1999
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.Nature Medicine, 1996
- CLINICAL IMPLICATIONS OF THE p53 GENEAnnual Review of Medicine, 1996
- Cell growth regulation in epithelial ovarian cancerCancer, 1993
- Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.Proceedings of the National Academy of Sciences, 1992
- A novel cationic liposome reagent for efficient transfection of mammalian cellsBiochemical and Biophysical Research Communications, 1991